BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1380162)

  • 1. Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin.
    Calvo V; Crews CM; Vik TA; Bierer BE
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7571-5. PubMed ID: 1380162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase.
    Price DJ; Grove JR; Calvo V; Avruch J; Bierer BE
    Science; 1992 Aug; 257(5072):973-7. PubMed ID: 1380182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of 70-kDa S6 kinase, induced by the cytokines interleukin-3 and erythropoietin and inhibited by rapamycin, is not an absolute requirement for cell proliferation.
    Calvo V; Wood M; Gjertson C; Vik T; Bierer BE
    Eur J Immunol; 1994 Nov; 24(11):2664-71. PubMed ID: 7957559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP.
    Monfar M; Lemon KP; Grammer TC; Cheatham L; Chung J; Vlahos CJ; Blenis J
    Mol Cell Biol; 1995 Jan; 15(1):326-37. PubMed ID: 7528328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or Fc epsilon RI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells.
    Tsai M; Chen RH; Tam SY; Blenis J; Galli SJ
    Eur J Immunol; 1993 Dec; 23(12):3286-91. PubMed ID: 7504992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of rapamycin to block proliferation once resting cells have entered the cell cycle despite inactivation of p70 S6 kinase.
    Terada N; Franklin RA; Lucas JJ; Blenis J; Gelfand EW
    J Biol Chem; 1993 Jun; 268(16):12062-8. PubMed ID: 8389370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin-sensitive phosphorylation of ribosomal protein S17 by p70 S6 kinase.
    Patel HR; Terada N; Gelfand EW
    Biochem Biophys Res Commun; 1996 Oct; 227(2):507-12. PubMed ID: 8878544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin inhibits the phosphorylation of p70 S6 kinase in IL-2 and mitogen-activated human T cells.
    Terada N; Lucas JJ; Szepesi A; Franklin RA; Takase K; Gelfand EW
    Biochem Biophys Res Commun; 1992 Aug; 186(3):1315-21. PubMed ID: 1380801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin inhibition of interleukin-2-dependent p33cdk2 and p34cdc2 kinase activation in T lymphocytes.
    Morice WG; Wiederrecht G; Brunn GJ; Siekierka JJ; Abraham RT
    J Biol Chem; 1993 Oct; 268(30):22737-45. PubMed ID: 8226784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase.
    Kuo CJ; Chung J; Fiorentino DF; Flanagan WM; Blenis J; Crabtree GR
    Nature; 1992 Jul; 358(6381):70-3. PubMed ID: 1614535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell receptor activation of a ribosomal S6 kinase activity.
    Calvo V; Bierer BE; Vik TA
    Eur J Immunol; 1992 Feb; 22(2):457-62. PubMed ID: 1537381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of p70/p85 S6 kinase activities in T cells by dexamethasone.
    Monfar M; Blenis J
    Mol Endocrinol; 1996 Sep; 10(9):1107-15. PubMed ID: 8885245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10 stimulation of phosphatidylinositol 3-kinase and p70 S6 kinase is required for the proliferative but not the antiinflammatory effects of the cytokine.
    Crawley JB; Williams LM; Mander T; Brennan FM; Foxwell BM
    J Biol Chem; 1996 Jul; 271(27):16357-62. PubMed ID: 8663063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The principal rapamycin-sensitive p70(s6k) phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases.
    Dennis PB; Pullen N; Kozma SC; Thomas G
    Mol Cell Biol; 1996 Nov; 16(11):6242-51. PubMed ID: 8887654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogen-activated protein kinases and ribosomal S6 protein kinases are involved in signaling pathways shared by interleukin-11, interleukin-6, leukemia inhibitory factor, and oncostatin M in mouse 3T3-L1 cells.
    Yin T; Yang YC
    J Biol Chem; 1994 Feb; 269(5):3731-8. PubMed ID: 7508917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-linking CD28 leads to activation of 70-kDa S6 kinase.
    Pai SY; Calvo V; Wood M; Bierer BE
    Eur J Immunol; 1994 Oct; 24(10):2364-8. PubMed ID: 7523138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-induced phosphorylation and activation of phosphodiesterase 3B in rat adipocytes: possible role for protein kinase B but not mitogen-activated protein kinase or p70 S6 kinase.
    Wijkander J; Landström TR; Manganiello V; Belfrage P; Degerman E
    Endocrinology; 1998 Jan; 139(1):219-27. PubMed ID: 9421418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational regulation during activation of porcine peripheral blood lymphocytes: association and phosphorylation of the alpha and gamma subunits of the initiation factor complex eIF-4F.
    Morley SJ; Pain VM
    Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):627-35. PubMed ID: 8526879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of the immunosuppressant rapamycin on the growth of rheumatoid arthritis (RA) synovial fibroblast.
    Migita K; Eguchi K; aoyagi T; Tsukada T; Tsuboi M; Kawabe Y; Nagataki S
    Clin Exp Immunol; 1996 Apr; 104(1):86-91. PubMed ID: 8603539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of ribosomal protein S6 kinase in psoriatic lesions and cultured human keratinocytes by epidermal growth factor receptor ligands.
    Choi JH; O'Connor TP; Kang S; Voorhees JJ; Fisher GJ
    J Invest Dermatol; 1997 Jan; 108(1):98-102. PubMed ID: 8980296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.